Multiple Hats is a STEM career podcast for professionals who want more than the 9–5. Hear real stories of STEM professionals reinventing their careers — from scientists turned founders to biotech consultants and entrepreneurs.
Hosted by Angelique Greco, a biotech and health-tech expert with 15+ years across the drug development lifecycle, this show explores how STEM careers can evolve into entrepreneurship, thought leadership, and portfolio work that truly matters.
Through in-depth conversations with entrepreneurial STEM professionals, you’ll discover:
You will hear:
For who:
Scientists, PhDs, engineers, clinicians, biotech consultants, tech pros including women balancing STEM careers with motherhood while fighting stereotypes.
Why listen:
Representation and role modelling matter. Bold and brave STEM professionals share how they carved their own paths — so you can too.
🎙 New episodes weekly. Follow now to reinvent your STEM career and design work on your own terms.
STEMM = Science Technology Engineering Mathematics Medicine
Visit my website https://angeliquegreco.com.au/ for short bite insights and on how to start crafting your message to set you on track for the career your want (Discover, Articulate, Master).
Hosted on Acast. See acast.com/privacy for more information.
Multiple Hats is a STEM career podcast for professionals who want more than the 9–5. Hear real stories of STEM professionals reinventing their careers — from scientists turned founders to biotech consultants and entrepreneurs.
Hosted by Angelique Greco, a biotech and health-tech expert with 15+ years across the drug development lifecycle, this show explores how STEM careers can evolve into entrepreneurship, thought leadership, and portfolio work that truly matters.
Through in-depth conversations with entrepreneurial STEM professionals, you’ll discover:
You will hear:
For who:
Scientists, PhDs, engineers, clinicians, biotech consultants, tech pros including women balancing STEM careers with motherhood while fighting stereotypes.
Why listen:
Representation and role modelling matter. Bold and brave STEM professionals share how they carved their own paths — so you can too.
🎙 New episodes weekly. Follow now to reinvent your STEM career and design work on your own terms.
STEMM = Science Technology Engineering Mathematics Medicine
Visit my website https://angeliquegreco.com.au/ for short bite insights and on how to start crafting your message to set you on track for the career your want (Discover, Articulate, Master).
Hosted on Acast. See acast.com/privacy for more information.
From pitch decks to de-risking strategies — how to turn promising research into an investible opportunity
You’ve got strong data and maybe even a breakthrough idea, but can you convince an investor or pharma partner that it’s worth their millions?
🔍 What You’ll Learn:
In this second part of the Drug Discovery Roadmap series, we move from the bench to the boardroom.
If you’re a STEM researcher or biotech founder wondering what turns great science into an investible opportunity, this episode unpacks it straight from investors, pharma veterans, and researchers who’ve been through the process.
You’ll learn:
• How to pitch your science to investors — what to include, what to leave out, and how to get a second meeting.
• Why a realistic, conservative market size matters more than billion-dollar dreams.
• The smart ways to de-risk your project — from alternate indications to veterinary and agricultural applications.
🎯 Play this episode to learn how to make your science fundable and credible in the eyes of those who write the cheques.
🧠 About the Guests:
Recorded live at the 2025 ARCS Drug Discovery Forum, this episode features insights from industry investors and researchers who’ve lived the highs and lows of drug translation:
📌 Episode Highlights:
00:00 Welcome back — what makes a project investible
02:00 Tim Boyle on building the bridge between research and industry
03:45 The number one startup killer: running out of capital
04:00 Mike Lamprecht on how to pitch science to investors
06:00 Market size myths — why “$10B market” slides backfire
08:00 The antibiotic paradox: when life-saving drugs still fail commercially
10:00 Diagnostics, payers, and the hidden gap between science and buyers
11:00 Daniel Beard on differentiating his stroke therapy
14:00 How to reframe your science for clarity and investor appeal
16:00 What clinicians need to see before trials
17:00 De-risking your project: alternate indications and sectors
19:00 The case for parallel applications — human, veterinary, agriculture
20:00 Why every biotech needs backup plans
21:00 Closing takeaways: the intersection of science, strategy, and story
♻️ Share this episode with researchers and biotech scientists and anyone trying to get their science to market.
Want to craft a career story that opens doors?
I help STEMM professionals speak with clarity, confidence, and purpose and show up as thought leaders —so the right opportunities find you.
📬 Let’s connect: angeliquegreco.com.au | LinkedIn
⭐️ Help More People Reinvent Their Careers
If you enjoyed this episode, please:
Hosted on Acast. See acast.com/privacy for more information.